Industry Symposia
Morning Symposia: Breakfast will be served to session participants from 07:00-07:30, half an hour prior to the start of the session.
Lunch Symposia: Lunch boxes will be served to session participants.
Admission to all industry symposia is included as part of the congress registration.
Friday, October 14, 2022
| 07:30-08:30 Hall A (Great Hall 1) |
Morning Industry Symposium The role of Enhertu (trastuzumab-deruxtecan) in changing the treatment paradigm for HER2-positive Metastatic Breast Cancer Supported by AstraZeneca |
 |
| 07:30-08:30 Hall B (Great Hall 2) |
Morning Industry Symposium: DCISionRT: Personalising treatment for women with DCIS Supported by GenesisCare/PreludeDX |
  |
| 07:30-08:30 Hall C (Room M1) |
Morning Industry Symposium: Risk adjusted screening Supported by Hologic |
 |
| 08:30-09:30 Hall C (Room M1) |
Industry Symposium: Evolution of treatment sequencing in patients with mTNBC Supported by Gilead |
 |
| 11:30-12:30 Hall B (Great Hall 2) |
Industry Symposium: Improving outcomes in high-risk HER2-positive patients post-KATHERINE Supported by an educational/research sponsorship by Roche |
 |
| 11:30-12:30 Hall C (Room M1) |
Industry Symposium: Touch and go: Removing the guesswork in detecting residual cancer Supported by OncoRes |
 |
Saturday, October 15, 2022
| 07:30-08:30 Hall A (Great Hall 1) |
Morning Industry Symposium: Future-proofing breast surgical guidance with Sentimag® A total magnetic conversion Supported by Endomag/GRC Surgical |
  |
| 07:30-08:30 Hall B (Great Hall 2) |
Morning Industry Symposium: Time to start CDK4&6 inhibition in EBC: Verzenio in HR+ HER2- node positive EBC at high risk of recurrence Supported by Lilly |
 |
| 07:30-08:30 Hall C (Room M1) |
Morning Industry Symposium: The role of the nurse in assessing, triaging and managing metastatic TNBC Supported by Gilead |
|
| 10:00-11:00 Hall B (Great Hall 2) |
Industry Symposium: A CDK4/6i is a ‘once in a lifetime treatment’ for patients with HR +ve HER2 -ve breast cancer Supported by Novartis |
 |
| 13:10-13:55 Hall B (Great Hall 2) |
Industry Lunch Symposium: Innovative approaches to help improve patient outcomes: Case-based discussion Supported by 3M |
 |